Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03298451 |
|---|---|
| Brief Title: | Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (HIMALAYA) |
| First Submitted : | September 19, 2017 |
| First Submitted that Met QC Criteria : | September 26, 2017 |
| First Posted : | October 2, 2017 |
| Last Update Submitted that Met QC Criteria : | February 24, 2020 |
| Last Update Posted : | February 25, 2020 |